Scopus BioPharma

About:

Scopus BioPharma is a biotechnology company that focused on developing therapeutics targeting serious diseases.

Website: https://scopusbiopharma.com

Twitter/X: ScopusSCPS

Description:

Scopus BioPharma Inc. is a biopharmaceutical company developing transformational therapeutics capitalizing on groundbreaking scientific and medical discoveries from leading research and academic institutions. The company's lead drug candidate is a novel, targeted immuno-oncology gene therapy for the treatment of multiple cancers. The company is also developing additional new chemical entities to treat other serious diseases with significant unmet medical needs, including systemic sclerosis.

Total Funding Amount:

$9M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

New York, New York, United States

Founded Date:

2018-04-01

Founders:

Morris Laster

Number of Employees:

11-50

Last Funding Date:

2021-01-27

IPO Status:

Public

Industries:

© 2025 bioDAO.ai